Statistics

Immunocellular Therapeuticsâ€™ work in industry-leading, next ...

www.immunocellulartherapeutics.com/

ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer vaccine ...

Immunocellulartherapeutics.com

Domain is redirected to: Imuc.com

Conversion Technology Metas Server

Immunocellulartherapeutics.com is hosted in United States / Saint Paul . Immunocellulartherapeutics.com doesn't use HTTPS protocol. Number of used technologies: 6. First technologies: CSS, Html, Javascript, Number of used javascripts: 16. First javascripts: Jquery.js, Jquery-migrate.js, Jquery-ui.js, Number of used analytics tools: 1. First analytics tools: Google Analytics, Its server type is: Microsoft-IIS/7.5. Its CMS is: DotNetNuke.

Technologies in use by Immunocellulartherapeutics.com

Technology

Number of occurences: 6

CSS
Html
Javascript
jQuery
jQuery Hover Intent
jQuery UI

Javascripts

Number of occurences: 16

jquery.js
jquery-migrate.js
jquery-ui.js
TWMenu.js
dnn.modalpopup.js
jquery.hoverIntent.min.js
dnncore.js
Common.js
bootstrap.min.js
jquery.ba-dotimeout.min.js
jquery.backstretch.min.js
Slide.js
Slider.js
home.js
jquery.nivo.slider.js
initWidgets.js

Content Management System

Number of occurences: 1

DotNetNuke

Analytics

Number of occurences: 1

Google Analytics

Server Type

Microsoft-IIS/7.5

Powered by

ASP.NET

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Founded!
CTA (call to action) button	Not founded!
List	Founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Immunocellulartherapeutics.com

Missing HTTPS protocol.

Meta - Immunocellulartherapeutics.com

Number of occurences: 10

Name:
Content: text/css
Name: DESCRIPTION
Content: ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer vaccine immunotherapies for the treatment brain, ovarian and other solid tumors.
Name: KEYWORDS
Content: ,DotNetNuke,DNN
Name: COPYRIGHT
Content: Copyright 2016 by Immunocellular Therapeutics, Ltd.All Rights Reserved
Name: GENERATOR
Content: DotNetNuke
Name: ROBOTS
Content: INDEX, FOLLOW
Name: RESOURCE-TYPE
Content: DOCUMENT
Name: REVISIT-AFTER
Content: 1 DAYS
Name: RATING
Content: GENERAL
Name: viewport
Content: width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0

Server / Hosting

IP: 208.88.78.6
Latitude: 45.01
Longitude: -93.15
Country: United States
City: Saint Paul

Rname

ns42.domaincontrol.com
ns41.domaincontrol.com
smtp.secureserver.net
mailstore1.secureserver.net

Target

dns.jomax.net

HTTP Header Response

HTTP/1.1 301 Moved Permanently Cache-Control: max-age=900 Content-Length: 0 Content-Type: text/html Location: http://www.imuc.com Server: Microsoft-IIS/7.5 X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET Date: Sat, 04 Jun 2016 20:29:33 GMT Age: 0 X-Cache: MISS from s_hk1 X-Cache-Lookup: MISS from s_hk1:80 Via: 1.1 s_hk1 (squid/3.5.9) Connection: keep-alive HTTP/1.1 200 OK Cache-Control: private Content-Length: 57990 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/7.5 Set-Cookie: um_IsMobile=False; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=u1IgpTH10QEkAAAAMzkzY2M3NDktZWVlNC00ZTc5LWE4M2YtNWU3YzAzMjE2NzU40; expires=Sat, 13-Aug-2016 07:09:34 GMT; path=/; HttpOnly X-AspNet-Version: 4.0.30319 Set-Cookie: um_IsMobile=False; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=u1IgpTH10QEkAAAAMzkzY2M3NDktZWVlNC00ZTc5LWE4M2YtNWU3YzAzMjE2NzU40; expires=Sat, 13-Aug-2016 07:09:34 GMT; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly X-Powered-By: ASP.NET X-Powered-By-Plesk: PleskWin Date: Sat, 04 Jun 2016 20:29:34 GMT X-Cache: MISS from s_hk1 X-Cache-Lookup: MISS from s_hk1:80 Via: 1.1 s_hk1 (squid/3.5.9) Connection: keep-alive